Page last updated: 2024-11-03

rabeprazole and Degenerative Diseases, Central Nervous System

rabeprazole has been researched along with Degenerative Diseases, Central Nervous System in 1 studies

Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Usman, H1
Tan, Z1
Gul, M1
Rashid, S1
Ali, T1
Shah, FA1
Li, S1
Li, JB1

Other Studies

1 other study available for rabeprazole and Degenerative Diseases, Central Nervous System

ArticleYear
Identification of novel and potential PPARĪ³ stimulators as repurposed drugs for MCAO associated brain degeneration.
    Toxicology and applied pharmacology, 2022, 07-01, Volume: 446

    Topics: Animals; Brain; Brain Ischemia; Ethambutol; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mol

2022